Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes

Journal:
The New England Journal of Medicine
Published:
DOI:
10.1056/nejmoa2505669
Affiliations:
4
Authors:
12
Go to article
Institutions Authors Share
Lilly, United States of America (USA)
9.000000
 0.75
Velocity Clinical Research, United States of America (USA)
2.000000
 0.17
Hospital Angeles Chihuahua, Mexico
1.000000
 0.08
Interested in Pharmacology and Pharmaceutical Sciences?